Systematic review / meta-analysis / 2021
Resveratrol supplementation showed no significant effect on bone mineral density or serum bone biomarkers in a meta-analysis of randomized controlled trials.
A systematic review and meta-analysis of 10 randomized controlled trials examined the effects of resveratrol supplementation on bone quality in 698 subjects. Resveratrol had no statistically significant effect on lumbar spine areal BMD (MD: -0.02, 95% CI: -0.05 to 0.01, p = 0.26), total hip BMD (MD: -0.01, 95% CI: -0.04 to 0.02, p = 0.65), or whole body BMD (MD: 0.00, 95% CI: -0.02 to 0.02, p = 0.74). It also did not significantly change serum bone markers including ALP, BAP, OCN, PINP, CTX, or PTH, with similar results observed across subgroups of dose, duration, and participant health status.
- Study type
- Systematic review and meta-analysis of RCTs
- Who was studied
- 698 subjects (401 receiving resveratrol, 297 receiving placebo) across 10 studies
- What was measured
- Bone mineral density (lumbar spine, total hip, whole body) and serum bone markers
THE PAPER
Effects of resveratrol supplementation on bone quality: a systematic review and meta-analysis of randomized controlled trials.
Li Q, Yang G, Xu H, Tang S, Lee WY. BMC Complement Med Ther, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.